Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 11:50 am Sale | 2021-12-31 | 13G | Teligent Inc. TLGT | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | -2,000,001 (Position Closed) | Filing History |
| 2022-02-14 11:46 am Purchase | 2021-12-31 | 13G | SCP & CO HEALTHCARE ACQUISITIO SHAC | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,732,445 6.030% | 1,732,445 (New Position) | Filing History |
| 2022-02-14 11:42 am Purchase | 2021-12-31 | 13G | NUANCE COMMUNICATIONS INC NUAN | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 19,010,713 5.950% | 19,010,713 (New Position) | Filing History |
| 2022-02-14 11:38 am Purchase | 2021-12-31 | 13G | PROVIDENCE ACQ CORP II UNI NPABU | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,227,500 7.130% | 2,227,500 (New Position) | Filing History |
| 2022-02-14 11:34 am Purchase | 2021-12-31 | 13G | NEWHOLD INVT CORP II COM NHIC | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,732,500 7.110% | 1,732,500 (New Position) | Filing History |
| 2022-02-14 11:28 am Purchase | 2021-12-31 | 13G | MAGELLAN HEALTH INC MGLN | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,366,939 5.190% | 1,366,939 (New Position) | Filing History |
| 2022-02-14 11:17 am Purchase | 2021-12-31 | 13G | HERON THERAPEUTICS INC HRTX | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,275,000 8.120% | 8,275,000 (New Position) | Filing History |
| 2022-02-14 11:12 am Purchase | 2021-12-31 | 13G | HOME PLATE ACQ.CORP COM HPLT | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,980,000 7.690% | 1,980,000 (New Position) | Filing History |
| 2022-02-14 11:05 am Sale | 2021-12-31 | 13G | GTY TECHNOLOGY HLDGS INC GTYH | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 758,000 1.320% | -4,655,674 (-86.00%) | Filing History |
| 2022-02-14 10:59 am Sale | 2021-12-31 | 13G | GREENSKY INC GSKY | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 698,553 0.760% | -6,255,302 (-89.95%) | Filing History |
| 2022-02-14 10:52 am Purchase | 2021-12-31 | 13G | GESHER I ACQUISITION CORP SHS GIAC | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,021,225 7.010% | 1,021,225 (New Position) | Filing History |
| 2022-02-14 10:46 am Purchase | 2021-12-31 | 13G | FAR PEAK ACQUISITION CORP FPAC | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,886,068 5.570% | 3,886,068 (New Position) | Filing History |
| 2022-02-14 10:41 am Sale | 2021-12-31 | 13G | SHARECARE, INC. CLASS SHCR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | -2,970,000 (Position Closed) | Filing History |
| 2022-02-14 10:37 am Purchase | 2021-12-31 | 13G | CONYERS PK III ACQ CORP COM CL CPAA | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,205,991 7.180% | 3,205,991 (New Position) | Filing History |
| 2022-02-14 10:34 am Sale | 2021-12-31 | 13G | AMRYT PHARMA PLC SPONSORED ADR AMYT | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 9,950,000 3.110% | -3,263,340 (-24.70%) | Filing History |
| 2022-02-14 10:29 am Sale | 2021-12-31 | 13G | JASPER THERAPEUTICS INC JSPR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | -50,000 (Position Closed) | Filing History |
| 2022-02-14 10:26 am Purchase | 2021-12-31 | 13G | ALPHA HEALTHCARE ACQUISITION C ALPA | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,485,000 7.510% | 1,485,000 (New Position) | Filing History |
| 2022-02-14 10:21 am Purchase | 2021-12-31 | 13G | AFTERNEXT HEALTHTECH ACQUISITI AFTR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,557,405 6.230% | 1,557,405 (New Position) | Filing History |
| 2022-02-14 10:16 am Sale | 2021-12-31 | 13G | ACORDA THERAPEUTICS INC NE ACOR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | -266,162 (Position Closed) | Filing History |
| 2022-02-14 10:09 am Purchase | 2021-12-31 | 13G | EVOLV TECHNOLOGIES HLDGS INC C EVLV | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,547,311 1.090% | 47,311 (+3.15%) | Filing History |